Looking At AstraZeneca"s Recent Unusual Options Activity
read more.....»»
Expert will testify Bryan Kohberger’s cell phone was outside of Moscow on the night of the Idaho murders, defense says
Expert will testify Bryan Kohberger’s cell phone was outside of Moscow on the night of the Idaho murders, defense says.....»»
Cell therapy firm acquires RTP manufacturing facility
A company that's backed by a venture capital firm in Raleigh is expanding its local footprint......»»
AstraZeneca"s Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Shows
AstraZeneca's updated data from TOPAZ-1 Phase 3 trial of Imfinzi (durvalumab) in advanced biliary tract cancer patients. Unveiling long-term survival benefits and significant overall survival improvement. read more.....»»
Security Ramped-Up In Germany After Jihadists Threaten Drone Strikes At Euro 2024
Security Ramped-Up In Germany After Jihadists Threaten Drone Strikes At Euro 2024 Authored by Thomas Brooke via ReMix News, An offshoot terror cell affiliated with Isl.....»»
Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program
Enliven Therapeutics' Phase 1 trial results for ELVN-001 in chronic myeloid leukemia (CML) patients. Explore the promising safety and efficacy data. read more.....»»
AbbVie-Roche Win European Approval for Venclyxto in Newly Diagnosed Acute Myeloid Leukemia
read more.....»»
Silence Therapeutics receives $40M from AstraZeneca in siRNA collaboration
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
: AstraZeneca’s $39 billion takeover of U.S.-based Alexion Pharmaceuticals examined by U.K. regulator
The deal has already been approved by the U.S. and Canadian authorities......»»
U.K."s CMA reviewing AstraZeneca"s proposed purchase of Alexion
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Kiromic submits IND for trial with potential for universal CAR T-cell therapy
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca CEO Soriot tells The Financial Times vaccine has a "future"
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Column: California"s stem cell program found a disease cure, but it"s being blocked by a biotech firm
A biotech firm has halted work on a state-funded disease cure, purely for its bottom line.A biotech firm has halted work on a state-funded disease cure, purely for its bottom line......»»
Oxford Secretly Used Millions Of Patients" Cell Phone Data For Vaccine "Mobility Study"
Oxford Secretly Used Millions Of Patients' Cell Phone Data For Vaccine 'Mobility Study' In a flagrant violation of patients' medical privacy that has just come to light, the British government h.....»»
AstraZeneca"s COVID vaccine Vaxzevria authorized for emergency use in Japan
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ford, SK Innovation announce MoU to create BlueOvalSK battery cell JV
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Incyte"s ponatinib meets primary endpoint in Phase 2 trial for leukemia
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
A Peninsula cell therapy company"s shares plunged 39% after its CEO resigned and the FDA raised manufacturing questions
Fardis had guided Iovance from being a little-know startup to the cusp of having an approved treatment. But the FDA request will set back its approval process by two years......»»
AstraZeneca to present update on ph3 trial of LYNPARZA in early breast cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»